跳至主要内容
临床试验/ACTRN12613000167763
ACTRN12613000167763进行中(未招募)未知

Single-arm prospective, interventional pilot study to evaluate the safety, feasibility and efficacy of the PROCEPT AquablationTM System (PAS) device for the treatment of Benign Prostatic Hyperplasia (BPH)

PROCEPT BioRobotics Corporation0 个研究点目标入组 30 人开始时间: 2013年2月12日最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
50 Years 至 o limit(—)
性别
Male

入选标准

  • Male, Age > 50 years with BPH and history of inadequate response to medical therapy.

排除标准

  • Large median lobe, urethral length >6cm, prostates >80g, prostate cancer, current urological conditions affecting procedural outcomes, previous prostate surgery, significant renal impairment, listed concomitant medications and listed uncontrolled co-morbidities.

研究者

相似试验

Aquablation Pilot Study for the treatment of Benign... | 临床试验